BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 22380018)

  • 1. The rat acute oral toxicity of trifluoromethyl compounds (TFMs): a computational toxicology study combining the 2D-QSTR, read-across and consensus modeling methods.
    Lu X; Wang X; Chen S; Fan T; Zhao L; Zhong R; Sun G
    Arch Toxicol; 2024 Jul; 98(7):2213-2229. PubMed ID: 38627326
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Banjare P; Singh R; Pandey NK; Matore BW; Murmu A; Singh J; Roy PP
    Toxicol Res (Camb); 2024 Feb; 13(1):tfae020. PubMed ID: 38496320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives.
    Wu L; Chen Y; Duan K
    Front Pharmacol; 2023; 14():1263933. PubMed ID: 37829302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to "Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals".
    Matthee C; Brown AR; Lange A; Tyler CR
    Environ Sci Technol; 2023 Oct; 57(39):14768. PubMed ID: 37733603
    [No Abstract]   [Full Text] [Related]  

  • 5. Cheminformatics and Machine Learning Approaches to Assess Aquatic Toxicity Profiles of Fullerene Derivatives.
    Fjodorova N; Novič M; Venko K; Rasulev B; Türker Saçan M; Tugcu G; Sağ Erdem S; Toropova AP; Toropov AA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Micellar Liquid Chromatography Technique and QSARs Modeling in Predicting the Blood-Brain Barrier Permeation of Heterocyclic Drug-like Compounds.
    Janicka M; Śliwińska A; Sztanke M; Sztanke K
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling in ecotoxicological risk assessment: application to the prediction of acute contact toxicity of pesticides on bees (Apis mellifera L.).
    Hamadache M; Benkortbi O; Hanini S; Amrane A
    Environ Sci Pollut Res Int; 2018 Jan; 25(1):896-907. PubMed ID: 29067614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of anticancer property of bowsellic acid derivatives by quantitative structure activity relationship analysis and molecular docking study.
    Satpathy R; Guru RK; Behera R; Nayak B
    J Pharm Bioallied Sci; 2015; 7(1):21-5. PubMed ID: 25709332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the maximum absorption wavelength of azobenzene dyes by QSPR tools.
    Xu X; Luan F; Liu H; Cheng J; Zhang X
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 83(1):353-61. PubMed ID: 21930420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QSTR modelling of the acute toxicity of pharmaceuticals to fish.
    Tugcu G; Saçan MT; Vračko M; Novič M; Minovski N
    SAR QSAR Environ Res; 2012; 23(3-4):297-310. PubMed ID: 22380018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSTR with extended topochemical atom (ETA) indices. 12. QSAR for the toxicity of diverse aromatic compounds to Tetrahymena pyriformis using chemometric tools.
    Roy K; Ghosh G
    Chemosphere; 2009 Nov; 77(7):999-1009. PubMed ID: 19709717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationship (QSAR) modeling of EC50 of aquatic toxicities for Daphnia magna.
    Katritzky AR; Slavov SH; Stoyanova-Slavova IS; Kahn I; Karelson M
    J Toxicol Environ Health A; 2009; 72(19):1181-90. PubMed ID: 20077186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
    Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.